Taejon, South Korea

Jong-Cheon Hahm

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Angiolab, Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jong-Cheon Hahm. Retrieved from https://idiyas.com/inventor/jong-cheon-hahm-il1axlgc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jong-Cheon Hahm: Innovator in Antiobesity Solutions

Introduction

Jong-Cheon Hahm is a notable inventor based in Taejeon, South Korea. He has made significant contributions to the field of health and wellness, particularly in the area of obesity management. His innovative approach has led to the development of a unique antiobesity composition.

Latest Patents

Jong-Cheon Hahm holds 1 patent for his invention titled "Antiobesity Composition." This patent provides a composition that includes an extract as an active ingredient, along with methods for suppressing obesity using this composition. His work addresses a critical health issue and offers potential solutions for those struggling with obesity.

Career Highlights

Throughout his career, Jong-Cheon Hahm has worked with various organizations, including Angiolab, Inc. His experience in these companies has contributed to his expertise in developing innovative health solutions.

Collaborations

Jong-Cheon Hahm has collaborated with notable individuals in his field, including Min-Young Kim and Hee-Suk Lee. These collaborations have likely enhanced his research and development efforts.

Conclusion

Jong-Cheon Hahm's contributions to the field of antiobesity solutions highlight his innovative spirit and dedication to improving health outcomes. His patent and collaborations reflect his commitment to addressing significant health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…